Loading
Yanuki
ARTICLE DETAIL
CRISPR-Based TB Test Using Tongue Swab Developed by Tulane University | Femtech Market Growth to $26 Billion by 2033: Key Insights and Opportunities | Preparing for Daylight Saving Time 2026: What You Need to Know | Oscar-Nominated Directors Highlight Workers at a Women's Health Clinic in 'The Devil Is Busy' | Trump Spotted with Rash on Neck: Possible Causes and Theories | Olympic Village Condom Shortage: A Hot Topic at the 2026 Winter Games | Talcum Powder and Cancer: Unveiling the Connection | Drug-Resistant Typhoid Fever: An Ancient Killer Returns | RFK Jr.'s CDC Panel to Discuss Covid Vaccine Injuries | CRISPR-Based TB Test Using Tongue Swab Developed by Tulane University | Femtech Market Growth to $26 Billion by 2033: Key Insights and Opportunities | Preparing for Daylight Saving Time 2026: What You Need to Know | Oscar-Nominated Directors Highlight Workers at a Women's Health Clinic in 'The Devil Is Busy' | Trump Spotted with Rash on Neck: Possible Causes and Theories | Olympic Village Condom Shortage: A Hot Topic at the 2026 Winter Games | Talcum Powder and Cancer: Unveiling the Connection | Drug-Resistant Typhoid Fever: An Ancient Killer Returns | RFK Jr.'s CDC Panel to Discuss Covid Vaccine Injuries

Health / Medical Devices

CRISPR-Based TB Test Using Tongue Swab Developed by Tulane University

Researchers at Tulane University have developed an innovative CRISPR-based tuberculosis (TB) test that utilizes a simple tongue swab for sample collection. This new approach aims to enhance community-based screenings and improve TB detectio...

Green Wave Hosts Sugar Bowl Fleet Races this Weekend
Share
X LinkedIn

tulane university
CRISPR-Based TB Test Using Tongue Swab Developed by Tulane University Image via Tulane University Athletics

Key Insights

  • **New TB Test:** Tulane University has created an improved CRISPR-based TB test using tongue swabs.
  • **Improved Detection Rates:** Clinical results indicate a 74% success rate in TB detection using tongue swabs, compared to 56% with conventional tests.
  • **High Sensitivity:** The test demonstrates high sensitivity in identifying TB in respiratory samples, pediatric stool samples, and adult spinal fluid samples.
  • **Rapid Results:** The ActCRISPR-TB method offers a streamlined diagnostic process, delivering results in less than an hour.
  • **"One Pot" Approach:** The test simplifies administration, requiring only a swabbed sample to be added to a tube pre-loaded with a test strip and reagent, with colored bands indicating infection presence after a 45-minute incubation period.
  • **Portable and Rapid Tests:** The research team has also developed portable rapid tests and utilized AI to identify drug resistance, ensuring patients receive the correct treatment more quickly.

In-Depth Analysis

The Tulane University team refined a CRISPR-based assay, enhancing its ability to identify TB in samples with low bacterial levels. The latest method, dubbed ActCRISPR-TB, demonstrated high sensitivity and specificity in various sample types, including respiratory specimens, pediatric stool, and adult spinal fluid. ActCRISPR-TB leverages a "one-pot" approach, simplifying the diagnostic process and reducing the need for specialized laboratory equipment. This streamlined method involves adding a swabbed sample to a pre-loaded tube with a test strip and reagent. After a 45-minute incubation, colored bands on the strip indicate the presence of infection, similar to a COVID-19 test. Clinical testing demonstrated that this new method is faster and more accurate than traditional tests, even when analyzing sputum nucleic acid. The study highlights the potential of ActCRISPR-TB to move TB testing out of the laboratory setting and into the community, reaching more people who may not otherwise be tested.

Read source article

FAQ

- **Q: What is the main advantage of the new TB test?

**

- **Q: How accurate is the new TB test?

**

- **Q: How quickly does the test provide results?

**

- **Q: What is the "one pot" approach?

**

- **Q: Can the test be used in low-resource settings?

**

Takeaways

  • The new CRISPR-based TB test offers a less invasive and more accessible alternative to traditional sputum-based tests.
  • It has shown improved detection rates and high sensitivity in various sample types.
  • The test's rapid results and "one pot" approach make it suitable for community-based screenings.
  • Portable rapid tests and AI-driven drug resistance identification further enhance patient care.
  • This innovation has the potential to significantly improve TB detection and treatment, especially in underserved communities.

Discussion

What do you think about using tongue swabs for TB testing? Share your thoughts and experiences in the comments below!

Share this article with others who need to stay ahead of this trend!

Sources

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.